Harvard Bioscience Announces Board and Executive Compensation Changes

Ticker: HBIO · Form: 8-K · Filed: Jun 13, 2025 · CIK: 1123494

Harvard Bioscience Inc 8-K Filing Summary
FieldDetail
CompanyHarvard Bioscience Inc (HBIO)
Form Type8-K
Filed DateJun 13, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: governance, executive-compensation, board-changes

TL;DR

Harvard Bioscience shakes up board, adjusts exec pay.

AI Summary

Harvard Bioscience, Inc. announced on June 10, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain directors and the election of new ones, alongside updates to compensatory arrangements for key officers.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy, governance, and future performance, impacting investor confidence.

Risk Assessment

Risk Level: medium — Changes in board and executive compensation can indicate internal shifts that may affect future strategy and performance.

Key Players & Entities

  • Harvard Bioscience, Inc. (company) — Registrant
  • June 10, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of Incorporation
  • 001-33957 (identifier) — Commission File Number
  • 04-3306140 (identifier) — I.R.S. Employer Identification No.
  • 84 October Hill Road, Holliston, MA 01746 (address) — Principal Executive Offices
  • (508) 893-8999 (phone_number) — Registrant's telephone number

FAQ

What specific items are being reported in this Form 8-K?

This Form 8-K reports on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements of certain officers, as well as financial statements and exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on June 10, 2025.

What is Harvard Bioscience, Inc.'s state of incorporation?

Harvard Bioscience, Inc. is incorporated in Delaware.

What is the principal executive office address for Harvard Bioscience, Inc.?

The principal executive office address is 84 October Hill Road, Holliston, MA 01746.

What is the SIC code for Harvard Bioscience, Inc.?

The Standard Industrial Classification (SIC) code for Harvard Bioscience, Inc. is 3826, which corresponds to Laboratory Analytical Instruments.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 regarding HARVARD BIOSCIENCE INC (HBIO).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.